Oral presentations given during the BSAVA Abstract sessions 24-26 May 2021. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin, and pyrantel against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe; Raw diets safe and nutritious? UK dog owner perspectives on raw diets compared to cooked diets; Evaluation of a point-of-care dot enzyme-linked immunosorbent assay to detect antibodies against canine parvovirus, distemper virus and adenovirus before revaccination; Cooling methods used in dogs with heat-related illness under UK primary veterinary care during 2016-2018; Vetcompass clinical grading tool for heat-related illness in dogs – a novel tool to support clinical decisionmaking in primary-care practice; The scoop on puppies that eat their own poop: is autocoprophagia retained as puppies age?; What makes dogs tick? Risk factors and clinical management of tick infestations in UK dogs; Concerns and experiences of accessing veterinary care during the COVID-19 pandemic: a mixed-methods analysis of dog owners’ responses; Euthanasia in dogs in the UK; what drives decision making?; Owner strategies for vaccination and revaccination in pedigree and non-pedigree dogs; Characterising first-line empirical treatment for coughing - a retrospective evaluation of 83 dogs; Vulval conformation in the entire bitch and the effects of pre and post-pubertal neutering on vulva development and urogenital disease; Journal advertising: what does it tell us?; Surgical safety checklists in veterinary practice: current implementation within UK practices and attitudes towards their use; Prevalence of alimentary and respiratory disease in brachycephalic dog breeds presenting to primary care practice; Retrospective study of feline lymphoma: distribution, clinical signs, nervous system involvement and diagnostic testing (2013-2019); Radiographic assessment and observer reliability in cases of implant loosening following canine total hip replacement (THR).